Skip to main content
SpringerLink
Log in

Häufige diagnostische Kategorien

  • Chapter
1 × 1 der Psychopharmaka

Zusammenfassung

Während in der Medizin die Ursache und Entstehungsweise (Pathogenese) vieler Symptome mehrdeutig ist (z.B. Fieber), sind in der Psychiatrie darüber hinaus auch die meisten Syndrome pathogenetisch mehrdeutig. Zum Beispiel kann ein depressives Geschehen körperlich (Diabetes), körperlich-funktionell (z.B. Neurotransmitterstörung bei Psychosen), oder umweltbedingt (seelische Krise) begründbar sein. Dazu kommt, dass die Ursache und Entstehungsweise einiger wichtiger psychiatrischer Erkrankungen noch unklar ist. Das Zusammenspiel von Ursache, Auslöser und aufrechterhaltenden Faktoren psychischer Störungen hat aber wesentliche Bedeutung für die Diagnose und eine umfassende Therapie.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • American Psychiatric Association (2001) Practice guidelines for the treatment of patients with borderline personality disorder. Am J Psychiatry 158(suppl) 10:1–52

    Google Scholar 

  • Amsterdam JD (1991) Refractory depression; advances in neuropsychiatry and psychopharmacology, vol 2. Raven, New York

    Google Scholar 

  • Angst J (1987) Switch from depression to mania, or from mania to depression: role of psychotropic drugs. Psychopharmacol Bull 23:66–67

    PubMed  CAS  Google Scholar 

  • Appels A, Bär F, Bär J et al (2000) Inflammation, depression and coronary artery disease. Psychosom Med 62:601–605

    PubMed  CAS  Google Scholar 

  • Ballanger JC (1988) The clinical of carbamazepine in affective disorders. J Clin Psychiat 49(Suppl):13–19

    Google Scholar 

  • Ban TA, Hippius H (1988) Thirty years CINP. Springer, Berlin Heidelberg New York

    Book  Google Scholar 

  • Benkert O, Hippius H (1986) Psychiatrische Pharmakotherapie. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Ben-Tovim DI, Walker K, Gilchrist P et al (2001) Outcome in patients with eating disorders: a 5 year study. Lancet 357:1254–1257

    Article  PubMed  CAS  Google Scholar 

  • Berndt ER, Koran LM, Finkelstein SN et al (2000) Lost human capital from early onset chronic depression. Am J Psychiatry 157:940–947

    Article  PubMed  CAS  Google Scholar 

  • Berner P (1982) Psychiatrische Systematik. Huber, Bern Stuttgart Wien

    Google Scholar 

  • Black DW, Winokur G, Nasrallah A (1987) The treatment of depression — electroconvulsive therapy versus antidepressants — a naturalistic evaluation of 1495 patients. Compr Psychiat 28:169–182 (10)

    Article  PubMed  CAS  Google Scholar 

  • Bouton ME, Mineka B, Barlow DH (2001) A modern learning theory perspective on the etiology of panic disorder. Psychol Rev 108:4–32

    Article  PubMed  CAS  Google Scholar 

  • Boyer P (2000) Do anxiety and depression have a common pathophysiological mechanism? Acta Psychiat Scand (Suppl 406) 24–29

    Google Scholar 

  • Byerley WF, Reimherr FW, Wood DR, Grosser BL (1988) Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression. J Clin Psychopharmacol 8:112–115

    Article  PubMed  CAS  Google Scholar 

  • Chan CH, Janicak PG, Davis JM et al (1987) Response of psychotic and non psychotic depressed patients to tricyclic antidepressants. J Clin Psychiat 48:197–200 (7)

    CAS  Google Scholar 

  • Checkley S (1988) Monoamines, depression and antidepressant drugs. Pharmacopsychiatry 21:6–8

    Article  PubMed  CAS  Google Scholar 

  • Cohen S, Khan A, Johnson S (1987) Pharmacological management of manic psychosis in an unlocked setting. J Clin Psychopharmacol 7:261–263

    PubMed  CAS  Google Scholar 

  • Conklin HM, Curtis CE, Katsanis J, Iacono WG (2000) Verbal working memory impairment in schizophrenia patients and their first degree relatives: evidence from the digit span task. Am J Psychiatry 157:275–277

    Article  PubMed  CAS  Google Scholar 

  • Ellison JM (1989) The psychotherapist’s guide to pharmacotherapy. Yearbook Med Publ, Chicago London Boca Raton

    Google Scholar 

  • Feighner JP, Boyer WF (1991) Selective serotonin re-uptake inhibitors. John Wiley & Sons, Chichester New York

    Google Scholar 

  • Friedmann A (1992) Leitfaden der Psychiatrie. Maudrich, Wien München Berlin

    Google Scholar 

  • Grenn AR (1988) The mechanism of action of antidepressant treatments: basic aspect. Pharmacopsychiatry 21:3–5

    Article  Google Scholar 

  • Haag H, Heidorn A, Haag M, Greil W (1987) Sequence of affective polarity and lithium responses: preliminary report on Munich sample. Prog Neuropsychopharmacol Biol Psychiat 11:205–208

    Article  CAS  Google Scholar 

  • Haase HJ (1982) Therapie mit Psychopharmaka und anderen psychotropen Medikamenten. Schattauer, Stuttgart

    Google Scholar 

  • Jaspers K (1973) Allgemeine Psychopathologie. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Kasen S, Cohen P, Skodol AE, Johnson JG, Brook JS (1999) Influence of Child and Adolescent Psychiatric Disorder on Young Adult Personality Disorder. Am J Psychiatry156:10, 1529–1535

    PubMed  CAS  Google Scholar 

  • Katona C (2000) Managing depression and anxiety in the elderly patient. European Neuropsychopharm 10(Suppl 4) 427–432

    Article  Google Scholar 

  • Kessler RC (2000) The epidemiology of pure and comorbid generalized anxiety disorder: a review and evaluation of recent research. Acta Psychiatr Scand 102 (suppl 406):7–13

    Article  Google Scholar 

  • Kessler RC (2003) Epidemiology of psychiatric comorbidity. In: Tusang MT, Tohen 6M, Zahner GEP (eds). Textbook in psychiatric epidemiology, 2nd ed, Wiley, New York

    Google Scholar 

  • Langer G, Heimann H (1983) Psychopharmaka. Springer, Wien

    Book  Google Scholar 

  • Laux G (1988) Psychopharmaka — ein Leitfaden. Fischer, Stuttgart New York

    Google Scholar 

  • Linde OK (1988) Pharmakopsychiatrie im Wandel der Zeit. Tilia, Klingenmünster

    Google Scholar 

  • Matussek N, Hippius H (1984) Tabulae psychiatricae et psychopharmacologicae. Aesophus, Basel

    Google Scholar 

  • McGorry PD, Yung A, Phillips LJ et al (2002) A randomized controlled trial of interventions designed to reduce the risk of progression to first episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 59:921–928

    Article  PubMed  Google Scholar 

  • Meryn S (1991) Schade, daß du schon gestorben bist. Strategien für ein persönliches Gesundheitsmanagement. Quintessenz, München

    Google Scholar 

  • Morey LC, Gunderson JG, Quigley BD, Shea MT (2002) The representation of borderline, avoident, obsessive-compulsive, and schizotypal personality disorders by the five-factor model. J Personal Disord 16:215–234

    Article  Google Scholar 

  • Muller B (1988) Psychotropics 88/89. Lundbeck, Heerlen Neth

    Google Scholar 

  • Müller C (1973) Lexikon der Psychiatric Springer, Berlin Heidelberg New York

    Book  Google Scholar 

  • Nutt D (2000) Treatment of depression and concomitant anxiety. European Neuropsychopharm 10(suppl 4):433–437

    Article  Google Scholar 

  • Pare CMB (1987) Monoamine oxidase inhibitors in the treatment of affective disorders. Psychiat Ann 17:309–335

    Google Scholar 

  • Paterniti S et al (2001) Sustained anxiety linked to progression of carotid atherosclerosis in men. Arterioscler Thromb Vasc Biol 21:136–141

    Article  PubMed  CAS  Google Scholar 

  • Paykel ES, Vanwoerkom AE (1987) Pharmacologic treatment of resistant depression. Psychiat Ann 17:327–335

    Google Scholar 

  • Pöldinger W, Gander G (1979) Psychopharmaka in der Praxis. Roche, Paris

    Google Scholar 

  • Pöldinger W, Schmidlin P, Wider F (1983) Index psychopharmacorum. Huber, Bern

    Google Scholar 

  • Rees I (1987) Developments in the pharmacologic treatment of affective disorders. Psychiat Ann 17:297–300

    Google Scholar 

  • Saletu B (1989) Biologische Psychiatrie. Thieme, Stuttgart New York

    Google Scholar 

  • Scott J, Barker WA, Eccleston D (1988) The Newcastle chronic depression study: patient characteristics and factors associated with chronicity. Br J Psychiat 152:28–33

    Article  CAS  Google Scholar 

  • Skodol AE, Siever LJ, Livesley WJ et al (2002) The borderline diagnosis II: biology, genetics and clinical course. Biol Psychiatry 51:951–963

    Article  PubMed  Google Scholar 

  • Spector R, Rogers H, Roy D (1984) Psychiatry: common drug treatments; practical problems in medicine. Dunitz, London

    Google Scholar 

  • Spijker J, Gijl RV, de Graaf R, Nolen WA (2001) Determinants of poor 1 year outcome of DSM III R major depression in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiat Scand 103:122–130

    Article  PubMed  CAS  Google Scholar 

  • Wehr T (1987) Can antidepressants cause mania and worsen the course of affective illness. Am J Psychiat 144:1403–1411

    PubMed  CAS  Google Scholar 

  • Weickert TC, Goldberg TE, Gold JM et al (2000) Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry 57:907–913

    Article  PubMed  CAS  Google Scholar 

  • Wittchen HU, Kessler RC, Pfister H, Lieb M (2000) Why do people with anxiety disorders become depressed? A prospective longitudinal community study. Acta Psychiatr Scand (suppl 406): 14–23

    Google Scholar 

  • Young A (2001) Primary care physicians in US not managing depressive, anxiety disorders well; http://psychiatry.medscape.com/reuters/prof/2001/01/01.16/20010115publ003.html

Download references

Author information

Authors and Affiliations

  1. Seisgasse 9/13, A-1040, Wien, Austria

    Dr. Margot Schmitz (Universitätsdozent der Klinik für Psychiatrie der Universität Wien, Psychosozialer Dienst der Stadt Wien Qualitätssicherung)

  2. Gonzagagasse 15, A-1010, Wien, Austria

    Dr. Margot Schmitz (Universitätsdozent der Klinik für Psychiatrie der Universität Wien, Psychosozialer Dienst der Stadt Wien Qualitätssicherung)

Authors
  1. Dr. Margot Schmitz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schmitz, M. (2004). Häufige diagnostische Kategorien. In: 1 × 1 der Psychopharmaka. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-7985-1927-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-7985-1927-5_3

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-7985-1394-5

  • Online ISBN: 978-3-7985-1927-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation